Across TCGA pan-cancer cohorts, INKA2 mass-spec protein is linked to patient survival in 1 of 34 cancer types, making it a survival-associated INKA2 data layer compared with 26 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher INKA2 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated INKA2 expression acts as an unfavorable survival marker.

CCRCC are the cancer types where INKA2 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	DFS	Quartile	All	0.380	1.000	.014	4	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: INKA2 tumor-vs-normal RNA expression · all INKA2 data types